Friday, November 30, 2018 2:59:06 PM
Philadelphia area that specializes in making markets for options.
Sazonov attached zip files containing the quant trading code
$300 million in options daily. Susquehanna is known on Wall Street for its options trading.
The version that has Yass forking over a million bucks to a guy who made a golf shot, which paid for his hip surgery
McNeil didn’t use the money for hip surgery; he banked it.
Interesting there is a version of this story that involves a hip surgery that never happened. Interesting Susquehanna is found all over the implant market playing options.
I can hypothesize a strategy combining high frequency quant trading with options trading. If you`re running high frequency quant trading and options trading as separate entities I don't see the problem. If you hand these tools to say, me. I`ll have grand fantasies of combining the two into a single strategy.
Hoping I lose less money running fraction of a penny trades to sway the opinion of other algorithmic bots than I can make on the previous purchased options. If I did this, would this be simply amoral? or illegal market manipulations? Hopefully, if it's illegal, it would be like finding a needle in a haystack in the data produced by high frequency algorithmic trading. Then if you find the evidence, you`d have to prove it was a willing act not accidental, providing its even illegal. Not saying this even works as a strategy since I never tried it. It might not even work. I imagine a good target would be low volume low price to test this theory on, for obvious reasons.
_____________________
As far as Black Rock and or/ Black Stone. Is this just a covered bet on the implant market? If Zimmer produces a disruptive product that takes market share away from stryker. Stryker goes down Zimmer goes up and it equals out on black rocks portfolio to the point Black rock doesnt care who gets what?
I can hypothesize. In this simulation Im black rock, I don't care who gets what or the daily dealings of the commoner, I can control the horizontal and the vertical. There's a game I like to play. I`m playing to win. The name of the game is who can get the most money. In this simulation where is the most money to be made considering I own a majority share across the board? I think it's in equal growth of my portfolio. If everyone in my portfolio gets a piece of this disruptive technology. Then nobody has an advantage so you would assume it has a neutral value. But, everybody gets to drop a PR. I hypothesize this would have a positive impact across the board. Increased consumer sentiment across the board. People who have hip or knee surgery warn me not to do it. Pain and inflammation. Perhaps this new tech. is different. People crying about metallosis shattering, infection etc. have a negative impact on EPS at the end of the day, across the board. Decreased financial bleed across the board, through things like proving liability, paying out settlements once liability has been determined.Potentially losing the legacy doctor. All of these things I would assume have a positive impact on EPS across my portfolio.
This all depends on a simulation where I have complete control of all the chess pieces. Your realities mileage may vary. But I could spin facts to argue a Stryker narrative over the Zimmer narrative. K2M was playing ball with Amedica. Stryker acquires K2M, etc. The evidence is there, LOL. Therefore Zimmer has no edge over Stryker.
Recent SINT News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/27/2026 07:00:23 PM
- SINTX Technologies to Present at the LD Micro Invitational XVI Conference • Newsfile • 05/17/2026 07:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 09:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/14/2026 12:30:10 PM
- SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution • GlobeNewswire Inc. • 03/23/2026 01:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/20/2026 09:00:53 PM
- SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant • GlobeNewswire Inc. • 03/19/2026 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 01:02:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 01:00:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 02:00:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2026 01:35:38 PM
- SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms • GlobeNewswire Inc. • 02/18/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:45:54 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:44:43 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:43:48 AM
- SINTX Technologies to Participate in Noble Capital Markets’ Emerging Growth Virtual Equity Conference on February 4–5 • GlobeNewswire Inc. • 01/29/2026 02:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/12/2025 05:15:20 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/09/2025 10:01:07 PM
- Sidoti Events, LLC's Year-End Virtual Investor Conference • ACCESS Newswire • 12/09/2025 05:48:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 01:00:05 PM
- SINTX Technologies to Participate in Sidoti & Company Investor Conference • GlobeNewswire Inc. • 12/08/2025 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2025 01:00:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2025 01:35:26 PM
- SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants • GlobeNewswire Inc. • 12/01/2025 01:30:00 PM
